Position in CABA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,577,591
+$2,945,666 QoQ
Shares Held
1,471,895
+142.6% QoQ
Ownership
0.868%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 139 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in CABA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,365,122 across 562 Biotechnology names. CABA ranks #153 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in CABA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,577,591 | 1,471,895 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,631,925 | 606,664 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $910,331 | 415,677 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $947,979 | 405,120 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $717,503 | 472,042 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $678,925 | 490,200 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $986,443 | 434,557 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $107,493 | 22,774 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $512,925 | 68,573 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,573,660 | 209,476 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,147,241 | 138,645 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $532,441 | 34,983 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $192,616 | 14,920 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $13,397 | 1,620 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $14,300 | 1,546 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $32,500 | 50,000 | Shares | Defined | 2022-11-10 | |
| 2021-09-30 | $11,722 | 964 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,917 | 223 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $10,445 | 941 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $24,173 | 1,937 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,788 | 165 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $50,675 | 4,549 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $28,163 | 3,858 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||